Showing results (1-10 of 242) with videos related to
Sort By:
Pageof 25
Molecular Biosystems|August 16, 2008
Protein kinase CK2 as a druggable targetStefania Sarno, Lorenzo A PinnaThe Journal of Biological Chemistry|April 17, 2002
Unique activation mechanism of protein kinase CK2. The N-terminal segment is essential for constitutive activity of the catalytic subunit but not of the holoenzymeStefania Sarno, Paola Ghisellini, Lorenzo A PinnaBiomed Research International|November 12, 2015
The Selectivity of CK2 Inhibitor Quinalizarin: A ReevaluationGiorgio Cozza, Andrea Venerando, Stefania Sarno, et al.Biochimica Et Biophysica Acta|April 3, 2009
Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysisMauro Salvi, Stefania Sarno, Luca Cesaro, et al.Biochimica Et Biophysica Acta|October 4, 2005
Features and potentials of ATP-site directed CK2 inhibitorsStefania Sarno, Mauro Salvi, Roberto Battistutta, et al.Biochemical and Biophysical Research Communications|January 18, 2012
Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinantsMauro Salvi, Edlir Trashi, Oriano Marin, et al.Biochemical and Biophysical Research Communications|July 21, 2009
Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cellsMauro Salvi, Dong Xu, Yingyu Chen, et al.Biochemical and Biophysical Research Communications|September 5, 2002
Acidophilic character of yeast PID261/BUD32, a putative ancestor of eukaryotic protein kinasesSonia Facchin, Stefania Sarno, Oriano Marin, et al.Chemistry & Biology|November 22, 2005
Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazoleRoberto Battistutta, Marco Mazzorana, Stefania Sarno, et al.FEBS Letters|June 30, 2006
Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunitsMauro Salvi, Stefania Sarno, Oriano Marin, et al.Pageof 25